Mucin secretion pathway in airway epithelium

The "mucus secretion pathway in airway epithelium" is not a specific molecular target such as a protein, receptor, or gene, but rather a biological process involving multiple molecular components. Airway epithelial secretory cells produce and secrete large polymeric mucins (primarily MUC5B and MUC5AC) via regulated exocytic pathways. These mucins hydrate to form mucus, which is cleared by ciliated cells and is essential for trapping and removing pathogens and particulates from the lung. Mucin secretion occurs at both basal and stimulated rates, mediated by distinct exocytic molecular machineries and regulated by neural input, inflammatory signals, and second messengers. Dysregulation of this pathway is implicated in diseases like chronic bronchitis, asthma, COPD, and cystic fibrosis[1][2][3][4][5]. **Note:** - This entry is flagged as incorrect (`is_incorrect: true`) because "mucus secretion pathways" is a collective term describing a physiological process, not a canonical molecular target (such as a single receptor or enzyme). It is too broad for standard drug target classification, which typically refers to individual proteins or well-defined molecular complexes. - Individual components of this pathway, such as "Mucin 5B" (MUC5B), "Mucin 5AC" (MUC5AC), or regulatory proteins like "Munc13-2", "SNARE proteins" (VAMP8, SNAP23), or "CFTR" could be considered molecular targets for therapy. To obtain structured target information, it is necessary to specify a particular protein, enzyme, or receptor involved in the mucus secretion pathway.

Other names

Mucus secretion pathway in airway epitheliumAirway mucin secretionAirway mucus pathway

Mucin hydration and breakdown (mucolytics) Increased mucus clearance Reduction in mucus viscosity